News

Net profit of Gennex Laboratories rose 61.21% to Rs 3.74 crore in the quarter ended March 2026 as against Rs 2.32 crore during the previous quarter ended March 2025. Sales rose 51.15% to Rs 60.96 crore in the quarter ended March 2026 as against Rs 40.33 crore during the previous quarter ended March 2025.For the full year,net profit rose 14.52% to Rs 18.46 crore in the year ended March 2026 as against Rs 16.12 crore during the previous year ended March 2025. Sales rose 25.26% to Rs 172.74 crore in the year ended March 2026 as against Rs 137.90 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales60.9640.33 51 172.74137.90 25 OPM %9.655.01 -12.9819.69 - PBDT6.134.65 32 26.4923.54 13 PBT4.974.10 21 23.8421.55 11 NP3.742.32 61 18.4616.12 15 Powered by Capital Market - Live News

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Gennex Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12 May 2026.

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 16 April 2026.

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live News